Mark Gilbert
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
- Genetics 296
- Glioma Diagnosis and Treatment 295
-
- Brain Metastases and Treatment 84
- Co-authors
- Terri S. Armstrong (115 shared papers)Minesh P. Mehta (56 shared papers)Roger Stupp (10 shared papers)Kenneth Aldape (44 shared papers)Patrick Yung Wen (29 shared papers)Wolfgang Wick (10 shared papers)Timothy Francis Cloughesy (23 shared papers)David A. Reardon (12 shared papers)
- Journals
- Neuro-Oncology (108 papers)Journal of Neuro-Oncology (53 papers)Journal of Clinical Oncology (31 papers)Neuro-Oncology Advances (20 papers)Clinical Cancer Research (18 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Mark Gilbert
509 papers receiving 38.0k citations
Mark Gilbert's Hit Papers
Peers
Comparison fields: 5 of 167
- Genetics 21.2k
- Cancer Research 5.6k
- Oncology 6.4k
- Pulmonary and Respiratory Medicine 7.5k
- Neurology 3.2k
Countries citing papers authored by Mark Gilbert
This map shows the geographic impact of Mark Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gilbert more than expected).
Fields of papers citing papers by Mark Gilbert
This network shows the impact of papers produced by Mark Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gilbert. The network helps show where Mark Gilbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Gilbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 524 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Hit paper breakdown → | 2010 | 3183 |
| 2 | A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma Hit paper breakdown → | 2014 | 2296 |
| 3 | Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups Hit paper breakdown → | 2015 | 899 |
| 4 | Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions Hit paper breakdown → | 2020 | 877 |
| 5 | Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial Hit paper breakdown → | 2013 | 866 |
| 6 | Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma Hit paper breakdown → | 2016 | 818 |
| 7 | Challenges to curing primary brain tumours Hit paper breakdown → | 2019 | 728 |
| 8 | Correlation of O 6 -Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity Hit paper breakdown → | 2008 | 705 |
| 9 | Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma Hit paper breakdown → | 2010 | 674 |
| 10 | Immunotherapy response assessment in neuro-oncology: a report of the RANO working group Hit paper breakdown → | 2015 | 612 |
| 11 | Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001 Hit paper breakdown → | 2020 | 608 |
| 12 | Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System Hit paper breakdown → | 2010 | 599 |
| 13 | Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials Hit paper breakdown → | 2015 | 544 |
| 14 | IDH mutation in glioma: molecular mechanisms and potential therapeutic targets Hit paper breakdown → | 2020 | 485 |
| 15 | 2007 | 446 | |
| 16 | 2005 | 444 | |
| 17 | Longitudinal molecular trajectories of diffuse glioma in adults Hit paper breakdown → | 2019 | 422 |
| 18 | 2013 | 391 | |
| 19 | 2018 | 390 | |
| 20 | 1991 | 384 |
About Mark Gilbert
Mark Gilbert is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Neurology, having authored 524 papers that have together received 39.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (295 papers), Brain Metastases and Treatment (84 papers), Neuroblastoma Research and Treatments (34 papers), Cancer, Hypoxia, and Metabolism (27 papers), Cancer Immunotherapy and Biomarkers (23 papers), Radiomics and Machine Learning in Medical Imaging (22 papers), Meningioma and schwannoma management (21 papers) and Cancer Genomics and Diagnostics (21 papers). The work is most often cited by research in Genetics (21.2k citations), Cancer Research (5.6k citations), Oncology (6.4k citations), Pulmonary and Respiratory Medicine (7.5k citations) and Neurology (3.2k citations). Mark Gilbert has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Terri S. Armstrong, Minesh P. Mehta, Roger Stupp, Kenneth Aldape, Patrick Yung Wen, Wolfgang Wick, Timothy Francis Cloughesy, David A. Reardon, Kathleen R. Lamborn and Monika E. Hegi. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Journal of Clinical Oncology, Neuro-Oncology Advances and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.